Division of Pediatric Hematology and Oncology
-
November 11, 2024
An inspiring legacy
Family establishes ERDie Project in memory of daughter, Emma Ryleigh Dixon, to support pediatric bone cancer research at Monroe Carell Jr. Children’s Hospital at Vanderbilt. -
September 24, 2024
Hyundai Hope on Wheels award bolsters pediatric cancer research
Since 2007, Hyundai Hope on Wheels, which includes funding from Hyundai Motor America and local dealerships, has awarded more than $2 million in funding to pediatric cancer researchers at Monroe Carell Jr. Children’s Hospital at Vanderbilt. -
June 25, 2024
International trial introduces another curative option for sickle cell disease
The therapy, haploidentical bone marrow transplant with thiotepa and posttransplant cyclophosphamide, is as safe and more affordable than the recently FDA-approved myeloablative gene therapy and gene editing treatments. -
February 29, 2024
Michael DeBaun receives Paragon Award from the Doris Duke Charitable Foundation
Vanderbilt's Michael DeBaun, MD, MS, MPH, has received the Paragon Award for “Innovative Improvements to Clinical Care or Healthcare Delivery” from the Doris Duke Charitable Foundation (DDF). -
February 27, 2024
Multi-institutional study of Wilms tumor facilitates enrollment, optimizes treatment
Multi-institutional study finds that enrollment and outcomes were similar across various groups of children participating in therapeutic trials for Wilms tumor — the most common pediatric kidney cancer worldwide. -
October 26, 2023
Debra Friedman named deputy director of Vanderbilt-Ingram Cancer Center
Internationally recognized cancer survivorship expert Debra Friedman, MD, MS, has been named deputy director of Vanderbilt-Ingram Cancer Center -
September 27, 2023
Being treated for childhood cancer set Jason Schwartz on the path to his life’s work: treating childhood cancer
Cancer at the age of 13 forced him to give up his dream of professional football. While undergoing treatment, he found a new dream.